Vitamin D in fetal brain development.

[1]  Annamaria Colao,et al.  Vitamin D and Cancer , 2012, Front. Endocrin..

[2]  M. Dealberto.  Prevalence of autism according to maternal immigrant status and ethnic origin , 2011, Acta psychiatrica Scandinavica.

[3]  S. Yılmazer,et al.  The Effects of Vitamin D Receptor Silencing on the Expression of LVSCC-A1C and LVSCC-A1D and the Release of NGF in Cortical Neurons , 2011, PloS one.

[4]  D. Eyles,et al.  Maternal vitamin D deficiency alters the expression of genes involved in dopamine specification in the developing rat mesencephalon , 2010, Neuroscience Letters.

[5]  C. Gillberg,et al.  Prevalence of autism in children of Somali origin living in Stockholm: brief report of an at‐risk population , 2010, Developmental medicine and child neurology.

[6]  A. Mackay-Sim,et al.  Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update. , 2010, Schizophrenia bulletin.

[7]  C. Molloy,et al.  Plasma 25(OH)D concentration in children with autism spectrum disorder , 2010, Developmental Medicine & Child Neurology.

[8]  L. Miller,et al.  Association of autistic spectrum disorder with season of birth and conception in a UK cohort , 2010, Autism research : official journal of the International Society for Autism Research.

[9]  M. Humble,et al.  Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: Relations with season, age, ethnic origin and psychiatric diagnosis , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  N. Meguid,et al.  Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in Egyptian children with autism. , 2010, Journal of alternative and complementary medicine.

[11]  C. Gillberg,et al.  Serum levels of 25‐hydroxyvitamin D in mothers of Swedish and of Somali origin who have children with and without autism , 2010, Acta paediatrica.

[12]  D. Eyles.  Vitamin D and autism: does skin colour modify risk? , 2010, Acta paediatrica.

[13]  Melly S. Oitzl,et al.  Brain development under stress: Hypotheses of glucocorticoid actions revisited , 2010, Neuroscience & Biobehavioral Reviews.

[14]  P. Mortensen,et al.  The utility of neonatal dried blood spots for the assessment of neonatal vitamin D status. , 2010, Paediatric and perinatal epidemiology.

[15]  J. McGrath,et al.  NEONATAL VITAMIN D STATUS AND RISK OF SCHIZOPHRENIA: A POPULATION-BASED CASE-CONTROL STUDY , 2010, Schizophrenia Research.

[16]  I. Melle,et al.  A cross-sectional study of vitamin D deficiency among immigrants and Norwegians with psychosis compared to the general population. , 2010, The Journal of clinical psychiatry.

[17]  Paula E. Goines,et al.  The immune system's role in the biology of autism , 2010, Current opinion in neurology.

[18]  Shin-ichi Muramatsu,et al.  Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons , 2009, The Journal of Neuroscience.

[19]  D. Eyles,et al.  Developmental vitamin D deficiency causes abnormal brain development , 2009, Psychoneuroendocrinology.

[20]  G. Panzica,et al.  Neuroactive steroids: An update of their roles in central and peripheral nervous system , 2009, Psychoneuroendocrinology.

[21]  D. Eyles,et al.  Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain , 2009, Neuroscience Letters.

[22]  M. V. Magni,et al.  Effect of 1α,25‐dihydroxyvitamin D3 in embryonic hippocampal cells , 2009, Hippocampus.

[23]  W. Grant,et al.  Epidemiologic evidence for supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism , 2009, Dermato-endocrinology.

[24]  U. Meyer,et al.  In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders , 2009, Neuroscience & Biobehavioral Reviews.

[25]  M. Cekic,et al.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease , 2009, Frontiers in Neuroendocrinology.

[26]  D. Stein,et al.  Progesterone with Vitamin D Affords Better Neuroprotection against Excitotoxicity in Cultured Cortical Neurons than Progesterone Alone , 2009, Molecular medicine.

[27]  P. Mortensen,et al.  A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[28]  X. J. Sun,et al.  Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. , 2009, American journal of physiology. Endocrinology and metabolism.

[29]  R. Perez-Fernandez,et al.  1,25‐Dihydroxyvitamin D3 administration to 6‐hydroxydopamine‐lesioned rats increases glial cell line‐derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum , 2009, Journal of neuroscience research.

[30]  L. Ceglia.  Vitamin D and skeletal muscle tissue and function. , 2008, Molecular aspects of medicine.

[31]  F. Noble,et al.  Effects of nitrous oxide on dopamine release in the rat nucleus accumbens and expectation of reward , 2008, Neuroscience.

[32]  B. Ames,et al.  Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  D. Tishkoff,et al.  Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. , 2008, Endocrinology.

[34]  B. Hollis,et al.  Vitamin D Requirement During Pregnancy and Lactation , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  K. Borowicz,et al.  Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock. , 2007, European journal of pharmacology.

[36]  C. Wagner,et al.  Neonatal vitamin D status at birth at latitude 32°72′: evidence of deficiency , 2007, Journal of Perinatology.

[37]  A. Mackay-Sim,et al.  Maternal vitamin D depletion alters neurogenesis in the developing rat brain , 2007, International Journal of Developmental Neuroscience.

[38]  D. Eyles,et al.  Vitamin D deficiency during various stages of pregnancy in the rat; its impact on development and behaviour in adult offspring , 2007, Psychoneuroendocrinology.

[39]  W. Willett,et al.  The urgent need to recommend an intake of vitamin D that is effective. , 2007, The American journal of clinical nutrition.

[40]  L. Bodnar,et al.  High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. , 2007, The Journal of nutrition.

[41]  M. Holick,et al.  Vitamin D Deficiency in a Healthy Group of Mothers and Newborn Infants , 2007, Clinical pediatrics.

[42]  M. Maze,et al.  The Differential Effects of Nitrous Oxide and Xenon on Extracellular Dopamine Levels in the Rat Nucleus Accumbens: A Microdialysis Study , 2006, Anesthesia and analgesia.

[43]  D. Eyles,et al.  Developmental Vitamin D Deficiency Alters MK 801-Induced Hyperlocomotion in the Adult Rat: An Animal Model of Schizophrenia , 2006, Biological Psychiatry.

[44]  C. Wagner,et al.  Vitamin D deficiency during pregnancy: an ongoing epidemic. , 2006, The American journal of clinical nutrition.

[45]  A. Papadopoulou,et al.  Low Vitamin D Status in Mother-Newborn Pairs in Greece , 2006, Calcified Tissue International.

[46]  S. Saha,et al.  The incidence and prevalence of schizophrenia varies with latitude , 2006, Acta psychiatrica Scandinavica.

[47]  C. Wagner,et al.  Nutritional vitamin D status during pregnancy: reasons for concern , 2006, Canadian Medical Association Journal.

[48]  A. Kalueff,et al.  Behavioural anomalies in mice evoked by “Tokyo” disruption of the Vitamin D receptor gene , 2006, Neuroscience Research.

[49]  Alan Mackay-Sim,et al.  Swimming behaviour and post-swimming activity in Vitamin D receptor knockout mice , 2006, Brain Research Bulletin.

[50]  H. Gronemeyer,et al.  Cross‐talk of vitamin D and glucocorticoids in hippocampal cells , 2006, Journal of neurochemistry.

[51]  A. Norman,et al.  Presence of a truncated form of the vitamin D receptor (VDR) in a strain of VDR-knockout mice. , 2005, Endocrinology.

[52]  M. Cannon,et al.  Risk for schizophrenia — broadening the concepts, pushing back the boundaries , 2005, Schizophrenia Research.

[53]  A. Kalueff,et al.  Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice , 2005, Brain Research Bulletin.

[54]  M. Cantorna,et al.  D-hormone and the immune system. , 2005, The Journal of rheumatology. Supplement.

[55]  Brent A Reynolds,et al.  Neural stem cells and neurospheres—re-evaluating the relationship , 2005, Nature Methods.

[56]  P. Rodier,et al.  The teratology of autism , 2005, International Journal of Developmental Neuroscience.

[57]  A. Mackay-Sim,et al.  Behavioural characterization of Vitamin D receptor knockout mice , 2005, Behavioural Brain Research.

[58]  J. McGrath,et al.  Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain , 2005, Journal of Chemical Neuroanatomy.

[59]  P. Rothwell,et al.  Timing of birth and risk of multiple sclerosis: population based study , 2004, BMJ : British Medical Journal.

[60]  D. Eyles,et al.  Maternal vitamin D3 deprivation and the regulation of apoptosis and cell cycle during rat brain development. , 2004, Brain research. Developmental brain research.

[61]  A. Mackay-Sim,et al.  Transient prenatal Vitamin D deficiency is associated with hyperlocomotion in adult rats , 2004, Behavioural Brain Research.

[62]  Peter B. Jones,et al.  Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study , 2004, Schizophrenia Research.

[63]  B. Joseph,et al.  p57Kip2 cooperates with Nurr1 in developing dopamine cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[64]  R. Yolken,et al.  Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera , 2003, Schizophrenia Research.

[65]  D. Eyles,et al.  Vitamin D receptor expression in the embryonic rat brain , 2003 .

[66]  D. Eyles,et al.  1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons , 2003, Neuroscience Letters.

[67]  A. Mackay-Sim,et al.  Vitamin d3 and brain development , 2003, Neuroscience.

[68]  T. Chiu,et al.  Systemic Vitamin D3 Attenuated Oxidative Injuries in the Locus Coeruleus of Rat Brain , 2003, Annals of the New York Academy of Sciences.

[69]  F. Glorieux,et al.  Conventional and tissue‐specific inactivation of the 25‐hydroxyvitamin D‐1α‐hydroxylase (CYP27B1) , 2003, Journal of cellular biochemistry.

[70]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[71]  R. Balling,et al.  Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. , 2002, Molecular endocrinology.

[72]  C. Suschek,et al.  Comparing Nitrosative Versus Oxidative Stress toward Zinc Finger-dependent Transcription , 2002, The Journal of Biological Chemistry.

[73]  François Berger,et al.  New clues about vitamin D functions in the nervous system , 2002, Trends in Endocrinology & Metabolism.

[74]  Yulei Jiang,et al.  Targeted expression of human vitamin d receptor in the skin promotes the initiation of the postnatal hair follicle cycle and rescues the alopecia in vitamin D receptor null mice. , 2002, The Journal of investigative dermatology.

[75]  S. Abrams.  Nutritional rickets: an old disease returns. , 2002, Nutrition reviews.

[76]  L. Olson,et al.  Orphan Nuclear Receptor Nurr1 Is Essential for Ret Expression in Midbrain Dopamine Neurons and in the Brain Stem , 2001, Molecular and Cellular Neuroscience.

[77]  P. Carmeliet,et al.  Duodenal calcium absorption in vitamin D receptor–knockout mice: Functional and molecular aspects , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[78]  J. McGrath,et al.  Vitamin D: the neglected neurosteroid? , 2001, Trends in Neurosciences.

[79]  G. Jirikowski,et al.  Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat. , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[80]  R. Wood,et al.  1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line , 2001, BMC Physiology.

[81]  M. Tremblay,et al.  Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[82]  B. Hoffer,et al.  Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats , 2001, Brain Research.

[83]  S. Shimohama,et al.  Protective effects of 1α,25-(OH)2D3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture , 2001, Neuropharmacology.

[84]  J. P. Herman,et al.  Evidence of functional vitamin D receptors in rat hippocampus , 2001, Neuroscience.

[85]  A. Howie,et al.  Extrarenal Expression of 25-Hydroxyvitamin D3-1α-Hydroxylase1 , 2001 .

[86]  Philip W. Landfield,et al.  Vitamin D Hormone Confers Neuroprotection in Parallel with Downregulation of L-Type Calcium Channel Expression in Hippocampal Neurons , 2001, The Journal of Neuroscience.

[87]  J. Zou,et al.  Correlation of a unique 220-kDa protein with vitamin D sensitivity in glioma cells. , 2000, Biochemical pharmacology.

[88]  N. Kathmann,et al.  Electrophysiological evidence for reduced latent inhibition in schizophrenic patients , 2000, Schizophrenia Research.

[89]  R. Schwartz,et al.  Nutritional rickets in African American breast-fed infants. , 2000, The Journal of pediatrics.

[90]  P. Brachet,et al.  Rat oligodendrocytes express the vitamin D3 receptor and respond to 1,25‐dihydroxyvitamin D3 , 2000, Glia.

[91]  T. Veenstra,et al.  Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord , 1999, Journal of Chemical Neuroanatomy.

[92]  S. Brimijoin,et al.  1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo , 1998, Brain Research.

[93]  P. Brachet,et al.  Expression of inducible nitric oxide synthase during rat brain inflammation: Regulation by 1,25‐dihydroxyvitamin D3 , 1998, Glia.

[94]  S. Appel,et al.  1α, 25 dihydroxyvitamin D3‐dependent up‐regulation of calcium‐binding proteins in motoneuron cells , 1998 .

[95]  W. Miller,et al.  Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. , 1997, Molecular endocrinology.

[96]  R. Yolken,et al.  Seasonality of births in schizophrenia and bipolar disorder: a review of the literature , 1997, Schizophrenia Research.

[97]  R. Baron,et al.  Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[98]  Tatsuya Yoshizawa,et al.  Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning , 1997, Nature Genetics.

[99]  M. Dehouck,et al.  1,25-dihydroxyvitamin D3 regulates γ-glutamyl transpeptidase activity in rat brain , 1996, Neuroscience Letters.

[100]  P. Brachet,et al.  1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor. , 1996, Brain research. Molecular brain research.

[101]  A. Windebank,et al.  1,25-Dihydroxyvitamin D(3) receptors in developing dorsal root ganglia of fetal rats. , 1996, Brain research. Developmental brain research.

[102]  B. Hempstead,et al.  p75 and Trk: A two-receptor system , 1995, Trends in Neurosciences.

[103]  M. Holick.  Environmental factors that influence the cutaneous production of vitamin D. , 1995, The American journal of clinical nutrition.

[104]  S. Christakos,et al.  Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation. , 1995, Molecular endocrinology.

[105]  P. Brachet,et al.  1,25‐Dihydroxyvitamin D3 regulates NT‐3, NT‐4 but not BDNF mRNA in astrocytes , 1994, Neuroreport.

[106]  P. Brachet,et al.  1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. , 1994, Brain research. Molecular brain research.

[107]  P. Brachet,et al.  Synthesis of 1,25‐dihydroxyvitamin D3 by rat brain macrophages in vitro , 1994, Journal of neuroscience research.

[108]  P. Brachet,et al.  Expression of 25(OH) vitamin D3 24-hydroxylase gene in glial cells. , 1993, Neuroreport.

[109]  R. Houlgatte,et al.  1,25‐Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis , 1991, Journal of neuroscience research.

[110]  M. Farach-Carson,et al.  Vitamin D3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. , 1989, The Journal of biological chemistry.

[111]  K. Haglid,et al.  Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[112]  T. Clemens,et al.  Tissue-specific regulation of avian vitamin D-dependent calcium-binding protein 28-kDa mRNA by 1,25-dihydroxyvitamin D3. , 1988, The Journal of biological chemistry.

[113]  M. Lieberherr.  Effects of vitamin D3 metabolites on cytosolic free calcium in confluent mouse osteoblasts. , 1987, The Journal of biological chemistry.

[114]  H. Thoenen,et al.  Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. , 1985, The EMBO journal.

[115]  W. Pardridge,et al.  Restricted Transport of Vitamin D and A Derivatives Through the Rat Blood‐Brain Barrier , 1985, Journal of neurochemistry.

[116]  H. Richter,et al.  25-hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid , 1984, Klinische Wochenschrift.

[117]  A. Siegel,et al.  Administration of 1,25-dihydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats , 1984, Brain Research.

[118]  P. Huet,et al.  Apparent [3H]1,25-dihydroxyvitamin D3 uptake by canine and rodent brain. , 1983, The American journal of physiology.

[119]  S. Yılmazer,et al.  A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons. , 2011, Journal of Alzheimer's disease : JAD.

[120]  P. Sambrook.  Glucocorticoids and Vitamin D , 2011 .

[121]  K. Munir,et al.  Environmental risk factors for autism: do they help cause de novo genetic mutations that contribute to the disorder? , 2010, Medical hypotheses.

[122]  D. Eyles,et al.  Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats , 2009, Psychopharmacology.

[123]  J. Cannell,et al.  Autism and vitamin D. , 2008, Medical hypotheses.

[124]  E. Coulson,et al.  The p75 neurotrophin receptor. , 2008, The international journal of biochemistry & cell biology.

[125]  C. Wagner,et al.  Neonatal vitamin D status at birth at latitude 32 degrees 72': evidence of deficiency. , 2007, Journal of perinatology : official journal of the California Perinatal Association.

[126]  Guilin Qiao,et al.  Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. , 2005, American journal of physiology. Endocrinology and metabolism.

[127]  E. Cantor-Graae,et al.  Schizophrenia and migration: a meta-analysis and review. , 2005, The American journal of psychiatry.

[128]  R. Narendran,et al.  Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. , 2005, Clinical therapeutics.

[129]  Steven A. Smith,et al.  Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. , 2005, Journal of chemical neuroanatomy.

[130]  Paul J. Harrison,et al.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.

[131]  E. Torrey,et al.  A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. , 2003, Schizophrenia bulletin.

[132]  E. Susser,et al.  In utero infection and adult schizophrenia. , 2002, Mental retardation and developmental disabilities research reviews.

[133]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. , 2002, The Journal of clinical investigation.

[134]  J. Prud’homme,et al.  Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. , 2001, Endocrinology.

[135]  S. Shimohama,et al.  Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. , 2001, Neuropharmacology.

[136]  P M Stewart,et al.  Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. , 2001, The Journal of clinical endocrinology and metabolism.

[137]  P. Brachet,et al.  1,25-Dihydroxyvitamin D3 regulates gamma 1 transpeptidase activity in rat brain. , 1996, Neuroscience letters.

[138]  D. Malamud.  Differentiation and the cell cycle , 1971 .